Patient Name: | AYESHA KHATOON | Ref. Doctor: | Dr. Rahgu Varun | Sample Billing Time: | 7/5/2023 11:50:00 AM | Patient Id: | 0001913271 | Lab Id: | 07232298854 | OP Id: | HY-VCM-0723-00021 | Sample Collection Date & Time: | 05/07/2023 11:55 AM | Age/Gender: | 45 Years/Female | Reporting Date & time: | 05/07/2023 10:20 PM |
|
| HAEMATOLOGY | COMPLETE BLOOD COUNT |
| Investigation | Result | Normal Reference Range |
|
| Specimen:Blood (K2EDTA) | Total Leukocyte Count | 5.92 X 10³/uL | 4.0-10.0 X 10³/uL | Total Red Blood Cell Count | 3.93 X10¹²/L | 3.8 - 4.8 X 10¹²/L | Hb | 10.3 g/dL | 12.0 - 15.0 g/dL | HCT | 36.1 % | 36 - 46 % | Mean Corpuscular Volume (MCV) | 91.9 fl | 83 - 101 fl | Mean Corpuscular Hemoglobin (MCH) | 26.2 pg | 27 - 32 pg | MCHC | 28.5 g/dl | 31.5 - 34.5 g/dl | Platelet Count | 224 X 10³/uL | 150 - 410 X 10³/uL | DIFFERENTIAL LEUKOCYTE COUNT | Neutrophils | 57.7 % | 2.0-7.5 X 10³/uL (40 - 80%) | Lymphocytes | 34.1 % | 1.0-4.0 X 10³/uL (20 - 40%) | Monocytes | 7.4 % | 0.2-1.0 X 10³/uL(2 - 10%) | Eosinophils | 0.8 % | 0.02-0.5 X 10³/uL (1-6%) | Basophils | 0.0 % | 0.02 - 0.1 X 10³/uL (1-2%) | Method | Flowcytometry | Notes | -- | *** END OF REPORT *** | | | Test Performed By : Clpath | Consultant Pathologist | |
Patient Name: | AYESHA KHATOON | Ref. Doctor: | Dr. Rahgu Varun | Sample Billing Time: | 7/5/2023 11:50:00 AM | Patient Id: | 0001913271 | Lab Id: | 07232298854 | OP Id: | HY-VCM-0723-00021 | Sample Collection Date & Time: | 05/07/2023 11:55 AM | Age/Gender: | 45 Years/Female | Reporting Date & time: | 06/07/2023 06:09 AM |
|
| CLINICAL BIOCHEMISTRY |
| Investigation | Result | Biological Reference Interval |
|
| Specimen:Whole Blood | HbA1c | 8.2 % | 4 - 6 % | Interpretation | : HbA1c is a form of hemoglobin that is measured primarily to identify the three-month average plasma glucose concentration |
| *** END OF REPORT *** | Please correlate clinically | | Test Performed By : cljyothi | Consultant Biochemist | |
Patient Name: | AYESHA KHATOON | Ref. Doctor: | Dr. Rahgu Varun | Sample Billing Time: | 7/5/2023 11:50:00 AM | Patient Id: | 0001913271 | Lab Id: | 07232298854 | OP Id: | HY-VCM-0723-00021 | Sample Collection Date & Time: | 05/07/2023 11:56 AM | Age/Gender: | 45 Years/Female | Reporting Date & time: | 05/07/2023 05:55 PM |
|
| CLINICAL BIOCHEMISTRY |
| Investigation | Result | Biological Reference Interval |
|
| Specimen:Flouride Plasma | Fasting Blood Glucose | 143 mg/dL | 74-106 mg/dL | Interpretation | : Glucose determination is useful in the diagnosis and treatment of Diabetes mellitus. Elevated levels are found in pancreatitis, pituitary and thyroid dysfunction, renal failure and liver diseases. Low glucose levels are found in insulinoma, hypopituitarism, neoplasms, insulin induced hypoglycemia |
| *** END OF REPORT *** | Please correlate clinically | | Test Performed By : cldakshyyani | Consultant Biochemist | |
Patient Name: | AYESHA KHATOON | Ref. Doctor: | Dr. Rahgu Varun | Sample Billing Time: | 7/5/2023 11:50:00 AM | Patient Id: | 0001913271 | Lab Id: | 07232298854 | OP Id: | HY-VCM-0723-00021 | Sample Collection Date & Time: | 05/07/2023 11:57 AM | Age/Gender: | 45 Years/Female | Reporting Date & time: | 05/07/2023 05:55 PM |
|
| CLINICAL BIOCHEMISTRY |
| Investigation | Result | Biological Reference Interval |
|
| Specimen:Flouride Plasma | Post Lunch Blood Glucose | 199 mg/dL | <140 mg/dL | Interpretation | : Glucose determination is useful in the diagnosis and treatment of Diabetes mellitus. Elevated levels are found in pancreatitis, pituitary and thyroid dysfunction, renal failure and liver diseases. Low glucose levels are found in insulinoma, hypopituitarism, neoplasms, insulin induced hypoglycemia |
| *** END OF REPORT *** | Please correlate clinically | | Test Performed By : cldakshyyani | Consultant Biochemist | |
Patient Name: | AYESHA KHATOON | Ref. Doctor: | Dr. Rahgu Varun | Sample Billing Time: | 7/5/2023 11:50:00 AM | Patient Id: | 0001913271 | Lab Id: | 07232298854 | OP Id: | HY-VCM-0723-00021 | Sample Collection Date & Time: | 05/07/2023 11:58 AM | Age/Gender: | 45 Years/Female | Reporting Date & time: | 06/07/2023 04:32 AM |
|
| CLINICAL BIOCHEMISTRY | LIPID PROFILE |
| Investigation | Result | Biological Reference Interval |
|
| Specimen:Serum | S.Total Cholesterol | 239 mg/dL | Desirable Level : <200 mg/dLBorderline : 200 - 239 mg/dLUndesirable : > 240 mg/dL | S.Triglycerides | 195 mg/dL | Desirable Level : <150 mg/dLBorderline : 150 - 199 mg/dLHigh : 200 - 499 mg/dLVery High : >500 mg/dL | S.HDL | 46 mg/dL | Desirable Level : >60 mg/dLBorderline : 40 - 59 mg/dLUndesirable : <40 mg/dL | VLDL | 39 mg/dL | <30 mg/dL | S.LDL | 154 mg/dL | Optimal : <100 mg/dLNear Optimal : 100 - 129 mg/dLBorderline High : 130 - 159 mg/dLHigh : 160 - 189 mg/dLVery High : >190 mg/dL | T.Chol/HDL | 5.2 | Low Risk: 3.3-4.4Average Risk: 4.5-7.1Moderate Risk: 7.2-11.0 | LDL/HDL | 3.3 | Desirable Level: 0.5-3.0Borderline Risk: 3.0-6.0High Risk: >6.0 | Interpretation | : The results of this test can identify certain genetic diseases and can determine approximate risks for cardiovascular disease, certain forms of pancreatitis, and other diseases |
| *** END OF REPORT *** | Please correlate clinically | | Test Performed By : cldakshyyani | Consultant Biochemist | |
Patient Name: | AYESHA KHATOON | Ref. Doctor: | Dr. Rahgu Varun | Sample Billing Time: | 7/5/2023 11:50:00 AM | Patient Id: | 0001913271 | Lab Id: | 07232298854 | OP Id: | HY-VCM-0723-00021 | Sample Collection Date & Time: | 05/07/2023 11:58 AM | Age/Gender: | 45 Years/Female | Reporting Date & time: | 06/07/2023 12:37 AM |
|
| CLINICAL BIOCHEMISTRY | LIVER FUNCTION TEST |
| Investigation | Result | Biological Reference Interval |
|
| Specimen:Serum | S. Bilirubin T | 0.43 mg/dL | 0.3 - 1.2 mg/dL | S. Bilirubin D | 0.12 mg/dL | <0.2 mg/dL | S.Total Protein | 6.05 gm/dL | 6.6 - 8.3 gm/dL | S.Albumin | 3.29 gm/dL | 3.5 - 5.2 gm/dL | Globulin | 2.76 gm/dL | 2.6-3.9 gm/dL | A/G Ratio | 1.19 | 1.0 - 1.7 | SGOT/AST | 16 U/L | < 35 U/L | SGPT /ALT | 16 U/L | < 35 U/L | S.Alkaline Phosphatase | 80 U/L | 30 - 120 U/L | Interpretation | : Liver function tests (LFTs or LFs) are groups of blood tests that give information about the state of a patient's liver. Liver transaminases (AST or SGOT and ALT or SGPT) are useful biomarkers of liver injury in a patient with some degree of intact liver function. Some tests are associated with functionality (e.g., albumin), some with cellular integrity (e.g., transaminase), and some with conditions linked to the biliary tract (gamma-glutamyl transferase and alkaline phosphatase). GGT plays a role in the detection of alcoholism, alcoholic liver damage and in monitoring alcohol abstinence. |
| *** END OF REPORT *** | Please correlate clinically | | Test Performed By : cljyothi | Consultant Biochemist | |
Patient Name: | AYESHA KHATOON | Ref. Doctor: | Dr. Rahgu Varun | Sample Billing Time: | 7/5/2023 11:50:00 AM | Patient Id: | 0001913271 | Lab Id: | 07232298854 | OP Id: | HY-VCM-0723-00021 | Sample Collection Date & Time: | 05/07/2023 11:58 AM | Age/Gender: | 45 Years/Female | Reporting Date & time: | 06/07/2023 12:53 AM |
|
| CLINICAL BIOCHEMISTRY | RENAL FUNCTION TEST |
| Investigation | Result | Biological Reference Interval |
|
| Specimen:Serum | Blood Urea | 32 mg/dL | 17 - 43 mg/dL | S.Creatinine | 1.0 mg/dL | 0.55 - 1.02 mg/dL | | *** END OF REPORT *** | Please correlate clinically | | Test Performed By : cljyothi | Consultant Biochemist | |
|